News & Updates

Brentuximab vedotin + chemo ups EFS in high-risk paediatric Hodgkin lymphoma

28 Jun 2022 by

The combination of brentuximab vedotin (Bv) and chemotherapy was superior to a standard paediatric dose-intensive chemotherapy regimen in boosting event-free survival (EFS) in paediatric patients with high-risk Hodgkin lymphoma (HL), according to the phase III AHOD1331* trial presented at ASCO 2022.

Brentuximab vedotin + chemo ups EFS in high-risk paediatric Hodgkin lymphoma

28 Jun 2022

COPD tied to earlier lung cancer diagnosis

27 Jun 2022 by

Chronic obstructive pulmonary disease (COPD) is associated with an earlier diagnosis of lung cancer, according to a cross-sectional, real-world study.

COPD tied to earlier lung cancer diagnosis

27 Jun 2022

Novel oral neoadjuvant therapy shows promising phase II results

25 Jun 2022

The novel neoadjuvant therapy S-1, an oral fluoropyrimidine agent containing tegafur, gimeracil, and oteracil potassium, yields promising survival outcomes in high-risk patients with resectable pancreatic ductal adenocarcinoma, a recent study has found.

Novel oral neoadjuvant therapy shows promising phase II results

25 Jun 2022

PPIs raise death risk in advanced NSCLC patients on antitumour therapy

25 Jun 2022

Treatment with proton pump inhibitors (PPI) appears to increase the risk of mortality among patients with advanced nonsmall cell lung cancer (NSCLC) undergoing systemic antitumour therapy, reveals a recent study.

PPIs raise death risk in advanced NSCLC patients on antitumour therapy

25 Jun 2022

Novel practice parameter ensures success of permanent brachytherapy of prostate cancer

25 Jun 2022

Permanent prostate brachytherapy can be delivered safely and effectively by adhering to established standards, suggests a recent study.

Novel practice parameter ensures success of permanent brachytherapy of prostate cancer

25 Jun 2022

KangDuo Surgical Robot-01 system feasible for robot-assisted radical prostatectomy

24 Jun 2022 by

Use of the KangDuo Surgical Robot-01 (KD-SR-01) system for the management of localized prostate cancer is safe and effective, according to the initial results of a prospective, single-centre study.

KangDuo Surgical Robot-01 system feasible for robot-assisted radical prostatectomy

24 Jun 2022

Colorectal cancer alters gut microbiome

24 Jun 2022 by

Patients with colorectal cancer (CRC) have a substantially altered gut microbiome, characterized by changes in bacterial composition, according to a recent Singapore study. Of note, these alterations persist even after surgery.

Colorectal cancer alters gut microbiome

24 Jun 2022

Handheld device can spot skin cancers without requiring biopsy

23 Jun 2022 by

A compact device that incorporates high-resolution millimetre-wave imaging (HR-MMWI) can diagnose malignant skin lesions as accurately as clinical examination and other detection techniques, potentially cutting the number of unnecessary biopsies in half, as reported in a study.

Handheld device can spot skin cancers without requiring biopsy

23 Jun 2022

Negative transrectal ultrasound biopsy tied to low prostate cancer death

23 Jun 2022

Prostate cancer-specific mortality is very low among men with negative transrectal ultrasound (TRUS) biopsies, particularly those with prostate-specific antigen (PSA) <10 ng/ml, reports a study.

Negative transrectal ultrasound biopsy tied to low prostate cancer death

23 Jun 2022

Is endoscopic submucosal dissection safe for rectal tumours extending to dentate line?

23 Jun 2022

Treatment with endoscopic submucosal dissection (ESD) for rectal tumours extending to the dentate line (RTDLs) remains safe and feasible despite its poorer outcomes relative to non-RTDLs if appropriate lesions are handled by experienced operators, suggests a study.

Is endoscopic submucosal dissection safe for rectal tumours extending to dentate line?

23 Jun 2022

News & Updates

Filter by Specialty:

Specialty:

Brentuximab vedotin + chemo ups EFS in high-risk paediatric Hodgkin lymphoma

Brentuximab vedotin + chemo ups EFS in high-risk paediatric Hodgkin lymphoma

COPD tied to earlier lung cancer diagnosis

COPD tied to earlier lung cancer diagnosis

Novel oral neoadjuvant therapy shows promising phase II results

Novel oral neoadjuvant therapy shows promising phase II results

PPIs raise death risk in advanced NSCLC patients on antitumour therapy

PPIs raise death risk in advanced NSCLC patients on antitumour therapy

Novel practice parameter ensures success of permanent brachytherapy of prostate cancer

Novel practice parameter ensures success of permanent brachytherapy of prostate cancer

KangDuo Surgical Robot-01 system feasible for robot-assisted radical prostatectomy

KangDuo Surgical Robot-01 system feasible for robot-assisted radical prostatectomy

Colorectal cancer alters gut microbiome

Colorectal cancer alters gut microbiome

Handheld device can spot skin cancers without requiring biopsy

Handheld device can spot skin cancers without requiring biopsy

Negative transrectal ultrasound biopsy tied to low prostate cancer death

Negative transrectal ultrasound biopsy tied to low prostate cancer death

Is endoscopic submucosal dissection safe for rectal tumours extending to dentate line?

Is endoscopic submucosal dissection safe for rectal tumours extending to dentate line?